Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECAP: Early Correction of Anemia in Chronic Renal Insufficiency
NCT00312871Phase 4Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2001
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 4 trial of epoetin alfa in anemia, sponsored by Janssen Pharmaceutical. Started Feb 2001; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00312871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312871.